Molecular characterization and risk analysis of Giardia duodenalis assemblages in corticosteroid-treated and non-treated patients in Ismailia, Arab Republic of Egypt

Table 4 Giardia duodenalis assemblages detected in patients on corticosteroid therapy (POCT) and controls (CONT)

No.	Group	Serial	Symp. Assoc.	tpi	bg	gdh	Assemblage detected	Positive/total
1	POCT	A21	1	―	―	B	B	15/21
2	POCT	A22	1	―	―	―	―
3	POCT	A23	2	―	―	―	―
4	POCT	A24	2	―	―	B	B
5	POCT	A25	2	B	―	―	B
6	POCT	A26	2	―	―	―	―
7	POCT	A27	2	―	―	B	B
8	POCT	A28	1	A	―	―	A
9	POCT	A29	2	A	―	―	A
10	POCT	A30	1	―	―	AII	A
11	POCT	A31	1	―	―	―	―
12	POCT	A32	2	A	―	B	A + B
13	POCT	A33	2	A	―	―	A
14	POCT	A34	2	A	―	B	A + B
15	POCT	A35	2	A^a	―	―	A
16	POCT	A36	2	―	―	AII	A
17	POCT	A37	1	―	―	―	―
18	POCT	A38	1	B	―	―	B
19	POCT	A39	1	A	―	B	A + B
20	POCT	A40	1	―	―	―	―
21	POCT	A41	2	A	―	―	A
22	CONT	B01	1	―	B	AII	A + B	23/31
23	CONT	B02	1	―	―	―	―
24	CONT	B03	1	B	B	B	B
25	CONT	B04	1	―	―	―	―
26	CONT	B05	1	―	―	―	―
27	CONT	B06	1	A	―	―	A
28	CONT	B07	1	―	―	―	―
29	CONT	B08	1	―	―	―	―
30	CONT	B09	1	―	―	―	―
31	CONT	B10	1	―	―	―	―
32	CONT	B11	1	―	―	―	―
33	CONT	C12	2	A	AII	AII	A
34	CONT	C13	2	B	B	B	B
35	CONT	C14	2	B	B	AII	A + B
36	CONT	C15	2	A	B	―	A + B
37	CONT	C16	2	B	AII	―	A + B
38	CONT	C17	2	B	B	E	B + E
39	CONT	C18	2	B	B	―	B
40	CONT	C19	2	B	B	―	B
41	CONT	C20	2	B	B	B	B
42	CONT	D42	1	―	B	E	B + E
43	CONT	D43	1	―	B	―	B
44	CONT	D44	1	A	AII	―	A
45	CONT	D45	2	―	B	―	B
46	CONT	D46	2	B	B^a	B	B
47	CONT	D47	2	B	B^a	AII	A + B
48	CONT	D48	2	B	B	B	B
49	CONT	D49	2	B	B	B	B
50	CONT	D50	1	B	B	B	B
51	CONT	D51	1	B	B^a	E	B + E
52	CONT	D52	2	A	B	―	A + B
Total				29/52	22/52	22/52	38/52

^aSequence excluded from the alignment due to poor coverage; ―: Not amplified
POCT Patients on corticosteroid therapy, CONT Controls, Symp. Assoc. Symptoms association, 1 Symptomatic, 2 Asymptomatic

ISSN: 1757-4749